PhRMA Calls Foul on CMS Policy to Destroy Documents After Price Negotiations

The latest guidance from the US Centers for Medicare and Medicaid Services (CMS) contains a clause that states that manufacturers must destroy all documents from the agency within 30 days after a therapeutic is no longer considered a selected drug. PhRMA, a major industry group, claims this practice is unconstitutional and overreaching, making the process less transparent.

According to Zachary Brennan, “The Big Pharma group, which has seen recent defections from AbbVie and Teva Pharmaceuticals, added in its 91 pages of written comments submitted last Friday that while these negotiation details would need to be destroyed on the manufacturer side, that same info might be available from CMS, after a records request under the Freedom of Information Act.”

To read more, click here.

(Source: Endpoints News, April 17^th, 2023)